{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T03:38:09Z","timestamp":1771472289744,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ahj.2021.05.001","type":"journal-article","created":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T11:13:00Z","timestamp":1620645180000},"page":"11-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Advanced heart failure patients supported with ambulatory inotropic therapy: What defines success of therapy?"],"prefix":"10.1016","volume":"239","author":[{"given":"Christopher S.","family":"Grubb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren K.","family":"Truby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veli K.","family":"Topkara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.","family":"Bohnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melana","family":"Yuzefpolskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ersilia M.","family":"DeFilippis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Kleet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichi","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer H.","family":"Haythe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Axsom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nir","family":"Uriel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Sayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan","family":"Garan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Naka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1066-9368","authenticated-orcid":false,"given":"Maryjane","family":"Farr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2021.05.001_bib0001","first-page":"757","article-title":"Ambulatory inotrope infusions in advanced heart failure: a systematic review and meta-analysis","volume":"6","author":"Nizamic","year":"2018","journal-title":"JACC: Heart Failure"},{"key":"10.1016\/j.ahj.2021.05.001_bib0002","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/jamacardio.2019.2081","article-title":"Palliative inotrope therapy: a narrative review","volume":"4","author":"Chuzi","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ahj.2021.05.001_bib0003","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/CIRCULATIONAHA.117.028747","article-title":"An unintended consequence of the 21st Century Cures Act for patients with heart failure","volume":"136","author":"Gilstrap","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2021.05.001_bib0004","first-page":"e240","article-title":"2013 ACCF\/AHA guideline for the management of heart failure","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2021.05.001_bib0005","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.healun.2012.02.027","article-title":"Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: Use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system","volume":"31","author":"Yang","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ahj.2021.05.001_bib0006","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.healun.2009.02.015","article-title":"INTERMACS profiles of advanced heart failure: the current picture","volume":"28","author":"Stevenson","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ahj.2021.05.001_bib0007","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJMoa012175","article-title":"Long-term use of a left ventricular assist device for end-stage heart failure","volume":"345","author":"Rose","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2021.05.001_bib0008","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1161\/01.CIR.0000078349.43742.8A","article-title":"Clinical use of inotropic therapy for heart failure: looking backward or forward?","volume":"108","author":"Stevenson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2021.05.001_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2006.08.003","article-title":"Chronic inotropic therapy in end-stage heart failure","volume":"152","author":"Hauptman","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2021.05.001_bib0010","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1111\/ajt.16010","article-title":"A change of heart: preliminary results of the US 2018 adult heart allocation revision","volume":"20","author":"Goff","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ahj.2021.05.001_bib0011","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(15)00723-0","article-title":"On behalf of the CHAMPION trial study group. Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow up results from the CHAMPION randomized trial","volume":"387","author":"Abraham","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2021.05.001_bib0012","unstructured":"Feasibility study of the intravascular ventricular assist systems (iVAS), [accessed 29 May 2021]. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02645539"},{"key":"10.1016\/j.ahj.2021.05.001_bib0013","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1089\/jpm.2014.0192","article-title":"Inpatient palliative care for patients with acute heart failure: outcomes from a randomized trial","volume":"18","author":"Sidebottom","year":"2015","journal-title":"J Palliative Med"},{"key":"10.1016\/j.ahj.2021.05.001_bib0014","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/jamainternmed.2016.1200","article-title":"Quality of end-of-life care provided to patients with different serious illnesses","volume":"176","author":"Wachterman","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ahj.2021.05.001_bib0015","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1001\/jamacardio.2018.2678","article-title":"Trends in hospice discharge and relative outcomes among medicare patients in the get with the guidelines-heart failure registry","volume":"3","author":"Warraich","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ahj.2021.05.001_bib0016","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/ejhf.1557","article-title":"Why has positive inotropy failed in chronic heart failure? Lessons from prior inotrope trials","volume":"21","author":"Ahmad","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ahj.2021.05.001_bib0017","first-page":"880","article-title":"Clinical characteristics and outcomes of intravenous inotropic therapy in advanced heart failure","volume":"8","author":"Hashim","year":"2015","journal-title":"Circ HF"},{"key":"10.1016\/j.ahj.2021.05.001_bib0018","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/CIRCULATIONAHA.118.036932","article-title":"Impact of bridge to transplantation with continuous-flow left ventricular assist devices on posttransplantation mortality","volume":"140","author":"Truby","year":"2019","journal-title":"Circulation"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870321001216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870321001216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:06:32Z","timestamp":1757570792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870321001216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":18,"alternative-id":["S0002870321001216"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2021.05.001","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advanced heart failure patients supported with ambulatory inotropic therapy: What defines success of therapy?","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2021.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}